Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Acetazolamide
Drug ID BADD_D00025
Description One of the carbonic anhydrase inhibitors that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
Indications and Usage For adjunctive treatment of: edema due to congestive heart failure; drug-induced edema; centrencephalic epilepsies; chronic simple (open-angle) glaucoma
Marketing Status Prescription; Discontinued
ATC Code S01EC01
DrugBank ID DB00819
KEGG ID D00218
MeSH ID D000086
PubChem ID 1986
TTD Drug ID D0E1SW
NDC Product Code 0143-9503; 0904-6663; 42291-090; 65841-762; 70954-034; 12658-0359; 51991-885; 70954-033; 42291-103; 23155-120; 71205-308; 12658-0592; 72789-238; 51991-884; 51672-4023; 62332-349; 16729-331; 51927-2276; 23155-787; 23155-313; 64380-834; 67123-001; 12658-0593; 50090-5945; 70756-720; 72888-048; 63629-1195; 23155-288; 50090-5593; 51927-0200; 50742-233; 60687-578; 0143-9006; 72789-045; 50090-0577; 50090-5617; 63629-1194; 71335-1370; 55289-720; 70771-1490; 52817-201; 71930-008; 63629-8257; 12658-0591; 50090-5217; 29033-030; 12817-363; 0527-1050; 70934-926; 46708-349; 64380-833; 71930-009; 60687-619; 72888-047; 50090-3003; 50268-054; 23155-287; 52817-200; 51672-4022; 68382-076; 62991-2517; 72789-237; 14593-801; 39822-0190; 68084-541; 70756-721; 38779-0410; 42419-008; 42291-089; 63629-7889; 50090-4511; 70710-1591; 49452-0018; 50090-3132
Synonyms Acetazolamide | Acetazolam | Acetazolamide Sodium, (Sterile) | Acetazolamide, Monosodium Salt | Ak-Zol | Ak Zol | AkZol | Apo-Acetazolamide | Apo Acetazolamide | ApoAcetazolamide | Diacarb | Diamox | Diuramide | Défiltran | Edemox | Glauconox | Glaupax | Huma-Zolamide | Huma Zolamide | HumaZolamide | Acetadiazol
Chemical Information
Molecular Formula C4H6N4O3S2
CAS Registry Number 59-66-5
SMILES CC(=O)NC1=NN=C(S1)S(=O)(=O)N
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
AcidosisCarbonic anhydrase 12O43570T169879987639; 11515988; 10509735
AcidosisParathyroid hormone/parathyroid hormone-related peptide receptorQ03431T677102156649; 8546173; 11287761; 7969674; 11379859; 15187195; 10814601; 9697664; 8807625; 10701159; 12671829; 8761540
AcidosisCarbonic anhydrase 12O43570T169872156649; 8546173; 11287761; 7969674; 11379859; 15187195; 10814601; 9697664; 8807625; 10701159; 12671829; 8761540; 2559040; 8555554; 8649655; 6348740; 10612998; 8592483; 2016806
Cardiovascular disorderCarbonic anhydrase 12O43570T169879987639; 11515988; 10509735
Cardiovascular disorderCarbonic anhydrase 12O43570T169872156649; 8546173; 11287761; 7969674; 11379859; 15187195; 10814601; 9697664; 8807625; 10701159; 12671829; 8761540; 2559040; 8555554; 8649655; 6348740; 10612998; 8592483; 2016806
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Agitation19.06.02.001; 17.02.05.012--
Agranulocytosis01.02.03.001--Not Available
Anaphylactic shock24.06.02.004; 10.01.07.002--Not Available
Anaphylactoid reaction10.01.07.003; 24.06.03.007--Not Available
Aplastic anaemia01.03.03.002--Not Available
Asthenia08.01.01.001--Not Available
Ataxia17.02.02.001; 08.01.02.004--
Body temperature increased13.15.01.001--Not Available
Confusional state19.13.01.001; 17.02.03.005--
Diarrhoea07.02.01.001--
Discomfort08.01.08.003--Not Available
Dizziness24.06.02.007; 17.02.05.003; 02.01.02.004--
Dysgeusia17.02.07.003; 07.14.03.001--
Dyspepsia07.01.02.001--
Electrolyte imbalance14.05.01.002--Not Available
Erythema multiforme23.03.01.003; 10.01.03.015--
Fatigue08.01.01.002--
Feeling abnormal08.01.09.014--Not Available
Flushing24.03.01.002; 23.06.05.003; 08.01.03.025--
Gastrointestinal disorder07.11.01.001--Not Available
Glycosuria20.02.01.005--
Haematuria24.07.01.047; 20.02.01.006--
Headache17.14.01.001--
Hepatic failure09.01.03.002--
Hepatic function abnormal09.01.02.001--Not Available
Hepatic necrosis09.01.07.002--
Hypoaesthesia17.02.06.023--Not Available
Hypoglycaemia05.06.03.001; 14.06.03.001--
Hypokalaemia14.05.03.002--
Hyponatraemia14.05.04.002--
The 1th Page    1 2 3    Next   Last    Total 3 Pages